Detalhe da pesquisa
1.
Use of covid-19 convalescent plasma to treat patients admitted to hospital for covid-19 with or without underlying immunodeficiency: open label, randomised clinical trial.
BMJ Med
; 2(1): e000427, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37920150